1. Market Research
  2. > Pharmaceutical
  3. > Biopharmaceutical Market Trends
Analyzing the Global Biosimilars Industry 2016

Analyzing the Global Biosimilars Industry 2016

  • July 2016
  • 285 pages
  • ID: 3991369
  • Format: PDF
  • Aruvian's R'search

Summary

Table of Contents

Search Inside

Biosimilars are the officially approved versions of biopharmaceutical products that are manufactured by a different company following the patent expiry of the original product. Also known as subsequent entry biologics or follow-on biologics, biosimilar drugs are gaining popularity around the world as the development cost of biosimilars is not as high as the original drug.

Also, the regulatory frameworks put in place by many countries are aiding the growth of biosimilars in the world, not to mention the lengthy tendering process of biologics that delays the actual launch of the drug. Meanwhile, biosimilar tendering is becoming more and more commonplace as the uptake of biosimilars is growing.

Aruvian Research analyzes the global biosimilars industry in its research report Analyzing the Global Biosimilars Industry 2016.

In this research report, we analyze what biosimilars are through an industry definition in the EU, US and Japan. We look at the development of biosimilars, the role of the Biologics Price Competition and Innovation Act, and the role of data exclusivity in the Patient Protection & Affordable Care Act for Biosimilars.

The specific nature of biosimilars and the types of biologics available and role of biosimilars are also analyzed, along with the importance of biosimilars and a comparison between biosimilars and generic drugs.

An overview of the biopharmaceutical industry in included in order to understand the growing importance of biosimilars.

Moving to the analysis of the global biosimilars industry, we analyze the market value, market size, upcoming patent expiries for branded biologics and the operating margins of biosimilar manufacturers. Market concerns regarding biosimilars is also included.

Factors driving the market for biosimilars, challenges and impacts on the industry, and industry growth factors, are all analyzed in this in-depth report.

We also take a look at the biosimilar market in developed markets and BRIC countries. Approval pathways and regulatory frameworks in the US, Europe, and Japan are analyzed, along with a comparison of European versus US legislation.

For companies wanting to enter the global biosimilars market, we carry out a market entry analysis through our section K of the report, Entering the Global Biosimilar Industry.

Analysis of competition in the industry is carried out through an analysis of the major industry players, industry suppliers, generic drug manufacturers, investors and stakeholders, major launches, and a country-wise analysis of the biosimilar industry. Biosimilar markets are analyzed in Australia, BRIC nations, EU, Japan, and the United States.

An analysis of Epoetin, Filgrastim, and Somatropin - the major biosimilars - is carried out, along with a look at the emerging opportunities for biosimilars due to the upcoming patent expiries.

The response of Big Pharma against the rise of biosimilars is detailed, followed by an analysis of the major markets and major industry players.

An industry forecast for the global biosimilars industry concludes our comprehensive and cutting-edge analysis of the Global Biosimilars Industry.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.

ref:plp2016

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on